
|Articles|May 7, 2019
Tufts CSDD: Adoption of AI is High Across Industry
Advertisement
The Tufts Center for Drug Development found in a recent analysis that the pharmaceutical industry is adopting artificial intelligence (AI) in numerous ways. 59% of respondents said they plan to expand artificial intelligence staff through 2020. The highest uses of AI are in clinical operations, safety/risk management, and information technology.
For more from the report, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement